What are the Medicare colonoscopy guidelines?

A colonoscopy costs $0 out of pocket under Medicare if it is a purely preventive screening. However, if a polyp or abnormal tissue is found and removed during the procedure, it becomes diagnostic, and you will typically owe a 15% coinsurance fee for both the doctor's services and the facility.

The exact out-of-pocket cost depends entirely on how the procedure is classified and billed:

1. Purely Preventive Screening: $0

If you have no prior symptoms and the doctor finds no polyps or abnormal tissue to remove, you pay nothing ($0).

• Medicare Part B covers 100% of the cost, including the anesthesia and facility fees.
• The annual Part B deductible does not apply.
• Note: To qualify for the $0 price, your doctor must accept Medicare assignment (agree to Medicare's approved payment amounts).

2. Screening that Becomes Diagnostic (Polyp Removal): 15% Coinsurance

If your doctor discovers and removes a polyp or performs a biopsy during a routine screening, the procedure changes from "preventive" to "diagnostic" for billing purposes.

• You will pay a 15% coinsurance of the Medicare-approved amount for the doctor's services and an additional 15% coinsurance for the facility fee (such as an ambulatory surgical center or outpatient hospital).
• The Part B deductible still does not apply in this scenario.
• On average, this 15% out-of-pocket cost typically comes out to roughly $200 to $300.
• Future Cost Note: This 15% coinsurance rate is part of a multi-year phase-out by the Centers for Medicare & Medicaid Services (CMS). The rate drops to 10% from 2027 to 2029, and will be completely waived ($0) starting in 2030.

3. Diagnostic from the Start: 20% Coinsurance

If you are having a colonoscopy because you already have symptoms (such as rectal bleeding or abdominal pain), it is classified as a diagnostic procedure from the beginning.

• You are responsible for the standard 20% coinsurance for the doctor's services.
• The annual Part B deductible will apply.

Hidden / Additional Costs to Keep in Mind

• Bowel Prep Kits: The laxatives and prep kits prescribed before your procedure are typically covered by Medicare Part D (prescription plans). Depending on your specific plan, you may owe a small copay.
• Follow-up Stool Tests: If you take an at-home stool screening test (like Cologuard) that comes back positive, Medicare covers the follow-up "second-line" screening colonoscopy at $0. However, if a polyp is removed during that follow-up, the 15% coinsurance rule mentioned above still applies.
• Supplemental Insurance: If you have a Medigap (Medicare Supplement) plan or a Medicare Advantage plan, it may cover some or all of the remaining 15% to 20% coinsurance fees. Always check your specific plan's summary of benefits before scheduling.

How Often Does Medicare Cover It?

Medicare covers a $0 preventive screening colonoscopy based on your risk factors:

• Average Risk: Once every 10 years (120 months), or 4 years after a flexible sigmoidoscopy.
• High Risk: Once every 2 years (24 months) if you have a personal or family history of colorectal cancer, polyps, or inflammatory bowel disease.

A virtual colonoscopy (CT colonography) and at-home stool or blood tests are the main alternatives instead of a traditional colonoscopy for colorectal cancer screening.

Virtual Colonoscopy

• What it is: A test that uses a CT scan and a small tube in the rectum to fill the colon with air, creating 3D images.
• Pros: It takes about 15 minutes, requires no sedation, and does not use a long camera tube.
• Cons: It still requires bowel preparation beforehand. If polyps are found, you must still get a traditional colonoscopy to remove them.

At-Home Stool Tests

• Cologuard: Checks stool samples for abnormal DNA and blood. It is done every 3 years.
• FIT (Fecal Immunochemical Test): Checks for hidden blood in the stool. It is done every year.
• Pros: Completely non-invasive with no bowel prep or sedation.
• Cons: If results are positive, you must follow up with a standard colonoscopy.

Blood Tests

• Shield: A newer FDA-approved blood test that detects DNA shed by cancer cells.
• Pros: Simple blood draw done in a clinic.
• Cons: Less effective at preventing cancer or finding early polyps compared to a direct look with a colonoscopy.

Routine colorectal cancer screening is generally no longer recommended after age 75, with screening strongly advised against or stopped entirely after age 85.

Age-Based Breakdown

• Ages 45 to 75: Routine, regular screening is recommended for average-risk adults by organizations like the U.S. Preventive Services Task Force (USPSTF) and the American Cancer Society.
• Ages 76 to 85: Screening is not routine and becomes a selective, individual choice. Decisions are made case-by-case based on overall health, life expectancy (greater than 10 years), prior screening history, and personal preferences.
• Age 85 and older: Screening is generally not recommended because potential risks outweigh benefits.

Exceptions to Consider

You and your doctor might discuss continuing screening past age 75 if:

• You have never been screened before.
• You are in excellent, robust health with a long life expectancy.
• You have high-risk factors like a strong family history of colon cancer or a personal history of precancerous polyps.

Non-invasive alternatives to a colonoscopy for older adults include at-home stool tests and imaging scans, though any abnormal result still requires a follow-up colonoscopy.

Stool-Based Tests

• FIT (Fecal Immunochemical Test): An annual at-home test that checks for hidden blood in the stool using antibodies. It requires no dietary restrictions.
• Stool DNA Test (such as Cologuard): An at-home test done every three years that checks for microscopic blood and abnormal DNA. It requires no bowel prep, but positive results require a follow-up colonoscopy.
• gFOBT (Guaiac Fecal Occult Blood Test): An annual test detecting blood through a chemical reaction, which requires avoiding specific foods and medications beforehand.

Imaging and Other Tests

• CT Colonography (Virtual Colonoscopy): A low-dose 3D X-ray scan done every five years. It requires bowel prep and gas inflation, but involves no sedation.
• Blood Test (such as Shield): A routine blood draw detecting circulating tumor DNA with no bowel prep, though it is less sensitive for precancerous polyps.
• Flexible Sigmoidoscopy: A partial scope examining only the lower third of the colon, performed every five to ten years.

For an average-risk 70-year-old woman with a history of normal screening results, a screening colonoscopy is generally recommended every 10 years, but routine screening typically stops at age 75.

Screening Guidelines for Age 70

• Average Risk: If your previous tests were completely normal and you have no symptoms or family history, you only need a colonoscopy once every 10 years.
• Prior Polyps: If a past procedure involved removing growths, your doctor likely advised a shorter follow-up window (such as every 3 to 7 years) based on the type and number of polyps.
• Increased Risk: Women with a family history of colorectal cancer, inflammatory bowel disease, or specific genetic syndromes require a customized, more frequent schedule.

Transitioning After Age 75

• Ages 75 to 85: Routine screening is generally no longer recommended for everyone. Decisions become individualized based on your overall health, life expectancy, and previous screening history.
• After Age 85: Major health organizations recommend stopping colorectal cancer screening entirely, as procedural risks (like bleeding, perforation, and severe dehydration from prep) often outweigh potential benefits.

You can review general tracking parameters through the American Cancer Society Guidelines.